MTOR and ductal breast carcinoma in situ: Histological samples from the two patients affected by ductal carcinoma in situ were characterized by a negativity of almost all parameters analyzed, with the exception of a low expression of TGFβ (score 1+) in one patient and a low mTOR expression (score 1+) in another.